DK162100C - Fremgangsmaade til fremstilling af steroidestere - Google Patents

Fremgangsmaade til fremstilling af steroidestere

Info

Publication number
DK162100C
DK162100C DK265484A DK265484A DK162100C DK 162100 C DK162100 C DK 162100C DK 265484 A DK265484 A DK 265484A DK 265484 A DK265484 A DK 265484A DK 162100 C DK162100 C DK 162100C
Authority
DK
Denmark
Prior art keywords
steroid esters
producing steroid
producing
esters
discoloured
Prior art date
Application number
DK265484A
Other languages
Danish (da)
English (en)
Other versions
DK265484D0 (da
DK162100B (da
DK265484A (da
Inventor
Anders Robert Stamvik
Sten Krister Kristensson
Karl-Erik Lundvall
Original Assignee
Leo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Ab filed Critical Leo Ab
Publication of DK265484D0 publication Critical patent/DK265484D0/da
Publication of DK265484A publication Critical patent/DK265484A/da
Publication of DK162100B publication Critical patent/DK162100B/da
Application granted granted Critical
Publication of DK162100C publication Critical patent/DK162100C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Amplifiers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK265484A 1983-05-30 1984-05-29 Fremgangsmaade til fremstilling af steroidestere DK162100C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8303031 1983-05-30
SE8303031A SE8303031D0 (sv) 1983-05-30 1983-05-30 Improved steroid esters preparation

Publications (4)

Publication Number Publication Date
DK265484D0 DK265484D0 (da) 1984-05-29
DK265484A DK265484A (da) 1984-12-01
DK162100B DK162100B (da) 1991-09-16
DK162100C true DK162100C (da) 1992-02-24

Family

ID=20351375

Family Applications (1)

Application Number Title Priority Date Filing Date
DK265484A DK162100C (da) 1983-05-30 1984-05-29 Fremgangsmaade til fremstilling af steroidestere

Country Status (18)

Country Link
US (1) US4537722A (ja)
EP (1) EP0127829B1 (ja)
JP (1) JPS6041696A (ja)
AT (1) ATE32603T1 (ja)
AU (1) AU560235B2 (ja)
CA (1) CA1211430A (ja)
DE (1) DE3469440D1 (ja)
DK (1) DK162100C (ja)
ES (1) ES532905A0 (ja)
FI (1) FI80710C (ja)
GR (1) GR82048B (ja)
HU (1) HU198217B (ja)
IE (1) IE57425B1 (ja)
IL (1) IL71870A (ja)
NZ (1) NZ208174A (ja)
PT (1) PT78661B (ja)
SE (1) SE8303031D0 (ja)
ZA (1) ZA843946B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
JP3441730B2 (ja) * 1993-01-19 2003-09-02 アンドルシェルシュ・インコーポレイテッド デヒドロエピアンドロステロンの治療用途およびデリバリーシステム
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US5892068A (en) * 1998-08-25 1999-04-06 Mcneil-Ppc, Inc. Preparation of sterol and stanol-esters
US6087522A (en) * 1999-10-12 2000-07-11 Fan Tech Corporation Silicone lanolin esters
ATE548375T1 (de) 2004-01-16 2012-03-15 Cedarburg Pharmaceuticals Inc Exemestan und zwischenprodukte davon und verfahren zu dessen herstellung
CN102264768B (zh) * 2008-11-10 2013-10-09 株式会社普利司通 改性天然橡胶、其生产方法和使用其的橡胶组合物以及轮胎

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1050883A (ja) *
DE1958954C3 (de) * 1969-11-24 1978-11-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Veresterung von Alkoholen
US3678082A (en) * 1970-07-30 1972-07-18 Searle & Co Esterification of 17-hydroxy steroids
GB1558472A (en) * 1976-01-22 1980-01-03 Leo Ab 17-esters of 17- hydroxy gestogens
GB1565680A (en) * 1976-12-31 1980-04-23 Leo Ab Method for the preparation of carboxylic acid esters

Also Published As

Publication number Publication date
CA1211430A (en) 1986-09-16
HUT34222A (en) 1985-02-28
FI80710B (fi) 1990-03-30
GR82048B (ja) 1984-12-12
PT78661B (en) 1986-06-26
HU198217B (en) 1989-08-28
PT78661A (en) 1984-06-01
ZA843946B (en) 1984-12-24
DE3469440D1 (en) 1988-03-31
NZ208174A (en) 1987-04-30
FI80710C (fi) 1990-07-10
EP0127829A3 (en) 1985-08-07
ES8503008A1 (es) 1985-02-01
DK265484D0 (da) 1984-05-29
US4537722A (en) 1985-08-27
EP0127829A2 (en) 1984-12-12
EP0127829B1 (en) 1988-02-24
ES532905A0 (es) 1985-02-01
SE8303031D0 (sv) 1983-05-30
FI842164A0 (fi) 1984-05-30
DK162100B (da) 1991-09-16
DK265484A (da) 1984-12-01
JPH0369360B2 (ja) 1991-10-31
AU560235B2 (en) 1987-04-02
IE841192L (en) 1984-11-30
JPS6041696A (ja) 1985-03-05
IE57425B1 (en) 1992-09-09
IL71870A0 (en) 1984-09-30
IL71870A (en) 1986-10-31
AU2883284A (en) 1984-12-06
ATE32603T1 (de) 1988-03-15
FI842164A (fi) 1984-12-01

Similar Documents

Publication Publication Date Title
ATE226960T1 (de) Verfahren zur herstellung von cardiodilatin- fragmenten, hochgereinigte cardiodilatin- fragmente und zwischenprodukte zu deren herstellung
DE69432109D1 (de) Synthetische, vielfache tandemwiederholungen des mucinpeptides und seiner derivate und deren verwendung
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
DE69713099D1 (de) Verfahren zur herstellung von xylitol
DK162100C (da) Fremgangsmaade til fremstilling af steroidestere
ATE305000T1 (de) Sysntheseverfahren zur herstellung von indolylquinonen und mono- und bis-indolylquinone, die durch das verfahren hergestellt sind
DE69607641D1 (de) Herstellung von amidoester-verbindungen
ATE237338T1 (de) Allogene parakrine cytokine tumor impfstoffe
DK0544826T3 (da) Overlegne trombomodulinanaloger til farmaceutisk anvendelse
DK209289A (da) Fremgangsmaade til fremstilling af indol-3-carboxylsyreestere af trans-hexahydro-8-hydroxy-2,6-methano-2h-quinolin-3(4h)-on
IE46290L (en) Improved method of preparing carboxylic acid esters
DE69322770D1 (de) Zyklische anti-tumorpromotor-verbindungen, zusammensetzungen und verfahren zur herstellung sowie ihre verwendung
ATE256664T1 (de) Herstellung von (s)-decahydroisochinolin-3- carbonsäure-t-butylamid
DE3580010D1 (de) Verfahren zur herstellung von carboxysaeureestern, alpha-halogenierte carbonate als zwischenprodukte und ihre herstellung.
ATE233321T1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
ATE8495T1 (de) Verfahren zur herstellung von fettsaeureestern.
BG98888A (en) Method for the preparation of 3-acylestratrienes and acylbezenes
SU553339A1 (ru) Способ анкеровки арматуры при изготовлении предварительно напр женных железобетонных изделий
ATE78828T1 (de) Verfahren und zwischenverbindungen fuer n-(s-3alkyl-heptanoyl)-d-gamma-glutamyl-glycyl-dalanine.
ATE28892T1 (de) Verwendung von salicylsaeureestern als riechstoffe, diese enthaltende riechstoffkompositionen, sowie neue salicylsaeureester.
ATE40679T1 (de) Verfahren zur herstellung von urethanen aus tertiaeren aralkyl-diolen.

Legal Events

Date Code Title Description
PUP Patent expired